Acute pilonidal abscess: Prospective nationwide audit in the Netherlands Authors: Eleonora A. Huurman, A. A. Sophie den Otter, Christel A. L. de Raaff, Rosaline van den Berg, Sara J. Baart, Bas P. L. Wijnhoven, Ruben Schouten, Edgar J. B. Furnée, Robert M. Smeenk, Boudewijn R. Toorenvliet, A. Moekotte, A. Moekotte, P. M. H. Nierop, W. Bleeker, H. Bouwman, A. van Erp, O. van Ruler, M. Vermaas, S. Ottenhof, H. Veger, S. Willems, I. J. M. Han‐Geurts, L. Dekker, J. Y. van Oostendorp, J. Konsten, T. Schok, G. Vijgen, S. Clermonts, H. Brokx, J. Diks, L. van Steensel, I. van Koeverden, F. H. W. Jonker, A. Emmen, T. Lettinga, I. Mulder, R. Klaassen, K. P. Jansen, M. W. G. A. Bronkhorst, M. J. Reiniers Published: 2024 ABSTRACT AbstractAimThe aim of this study was to assess Dutch surgical practice and outcomes for acute pilonidal abscess.MethodPatients with pilonidal sinus disease (PSD) who underwent surgical treatment between 1 March 2020 and 1 March 2021 at 36 participating hospitals were included in a prospective observational cohort study. For the present study, only patients with an acute abscess were included for analysis. Outcomes included symptoms, wound healing, time to resume daily activities and complications. Follow‐up was 1 year and included questionnaires on recurrent abscesses, symptomatic chronic PSD, quality of life and patient‐reported experience measures.ResultsOf 681 included patients, 208 presented with an acute pilonidal abscess. Incision and drainage (I&D) was performed in 205 of these patients (99%). The wound healing rate after I&D was 42.2% at the outpatient clinic, with a median time to closure of 43 days. The complication rate was 4.4%. One‐year questionnaires were completed by 158 out of 205 patients (77.1%). Fifteen patients (7.3%) had a recurrent abscess within 1 year. The symptomatic chronic PSD rate was 8.8%.ConclusionOf all the patients presenting with PSD in this prospective national study cohort, 30% had a pilonidal abscess. Incision and drainage showed a low complication rate but successful wound healing in less than half of the patients. The study showed that 91.2% of patients did not undergo additional surgical treatment for symptomatic chronic PSD within 1 year of follow‐up. What does this paper add to the literature?This study provides valuable data on the treatment of acute pilonidal abscesses in the Netherlands. It shows that 91.2% of patients did not require additional surgery for symptomatic chronic PSD within 1 year, suggesting that further surgical intervention may often be unnecessary after incision and drainage. What does this paper add to the literature? This study provides valuable data on the treatment of acute pilonidal abscesses in the Netherlands. It shows that 91.2% of patients did not require additional surgery for symptomatic chronic PSD within 1 year, suggesting that further surgical intervention may often be unnecessary after incision and drainage. INTRODUCTION Pilonidal sinus disease (PSD) predominantly affects young individuals and can manifest as either an acute abscess or a chronic condition with discharging pits or sinuses [1, 2, 3, 4]. Pilonidal abscesses are common surgical emergencies, typically managed through incision and drainage (I&D) [5, 6, 7]. Simple needle aspiration followed by antibiotics has also been described to be effective in 83%–95% of acute cases, preventing the need for emergent I&D. This strategy may facilitate subsequent elective surgery, resulting in high overall satisfaction rates [8, 9]. Others have reported a single‐step procedure for acute PSD by combining I&D with a surgical technique for chronic PSD. The authors concluded that this approach results in a short time to wound healing and low recurrence rates [10, 11, 12, 13, 14]. Guidelines recommend definitive treatment after the resolution of inflammation [15, 16]. However, the rationale for this recommendation is unclear as long‐term recurrence‐free healing can occur following I&D [7]. Given these uncertainties on preferred treatment for acute PSD and the lack of prospective studies this nationwide prospective study aimed to assess treatment and short and 1‐year outcomes for patients presenting with acute PSD. METHOD The Strengthening of the Reporting of Observational Studies in Epidemiology (STROBE) statement was used in the design and implementation of the study and to prepare the manuscript [17]. Study design All community hospitals in the Netherlands that provide surgical care for patients with PSD were invited to participate in this prospective observational study. All patients with PSD operated on at the participating hospitals were included during a 3‐month inclusion period between 1 March 2020 and 1 March 2021. The inclusion period commenced at each participating hospital upon receiving study approval from the local medical ethics committee. Therefore, not all hospitals started simultaneously. All patients were treated according to the local hospital protocols. Data collection In each participating hospital, one surgeon and a surgical resident were responsible for collecting the data and entering these in an anonymized fashion in a web‐based database [Castor Electronic Data Capture (EDC)©]. After recruitment and signed informed consent, a patient electronic case report form (eCRF) was created in Castor EDC©. Outcomes were collected during follow‐up visits at the outpatient clinic, preferably 1 week, 2 weeks and 6 weeks postsurgery (Data S1). Local hospital follow‐up protocols were allowed because this study aimed to assess everyday practice. To standardize classification of PSD, the Dutch classification system for PSD was used [18]. Acute PSD is classified as type II, and all other types relate to chronic PSD. For this study, only patients with acute PSD treated by I&D were included for analysis. Eligibility criteria and outcome measures This prospective observational study only included patients aged 16 years or older with symptomatic PSD who underwent surgery and provided written informed consent. Primary outcomes included the rate of recurrent abscesses and symptomatic chronic PSD within 1 year, for which patients returned to the hospital. Secondary outcomes included pre‐ and postoperative symptoms, type of anaesthesia, wound healing rates (defined as complete wound closure with no residual discharge at the last outpatient visit), time to wound healing in days, time to resume daily activities in days and the occurrence and type of postoperative complications. One year after surgical treatment for PSD, patients were invited to fill out questionnaires automatically sent by email through the electronic database Castor EDC© using the day of surgery as the reference date. A single reminder email was sent when patients had not completed the questionnaires within 2 weeks. The questionnaires inquired about recurrent abscesses treated by I&D, symptomatic chronic PSD (defined as patients undergoing additional surgery), quality of life (QoL) as measured with the EQ‐5D‐5L [19] and patient‐reported experience measures (PREMs). EQ‐5D‐5 contains five questions about five dimensions of QoL: mobility, self‐care, daily activities, pain/discomfort and anxiety/depression. The EQ‐5D levels were dichotomized into ‘no problems’ (level 1) and ‘any problems’ (levels 2, 3, 4 and 5). Five study‐designed questions assessed PREMs: (1) I am satisfied with the outcome of my surgery (yes/no); (2) I would recommend this surgery to other patients (yes/no); (3) I had no problems with my wound after the surgery (yes/no); (4) I was happy with the follow‐up after my surgery (yes/no); (5) I would again choose the same surgical procedure (yes/no). Statistical analysis Statistical analysis was performed using SPSS version 24.0 (SPSS Inc., Chicago, IL, USA). Continuous variables were evaluated for normal distribution using visual inspection. For continuous variables, normally distributed data were reported as means ± standard deviation (SD), and medians with interquartile range (IQR) were used in skewed data. Categorical data were reported as frequencies with percentages. The time until wound healing and resumption of daily activities has been visualized using the Kaplan–Meier method and analysed with the log‐rank test. Multivariable logistic regression analysis was conducted with successful healing at the last outpatient visit as outcome and risk factors considered to be associated with the outcome, including age, gender, history of PSD abscess, body mass index and smoking as independent variables. The other baseline characteristics were not included in the model due to the small number of cases and dependence between variables. Univariable logistic regression analysis was conducted with recurrent abscesses within 1 year as outcome. Based on the literature, smoking was the only factor considered for recurrent abscesses [20]. Due to the small number of observations with the outcome, a univariable logistic regression analysis was conducted. RESULTS A total of 36 (out of 66) Dutch hospitals participated in the study, and 681 eligible patients were included. Of these patients, 208 presented with acute PSD (Figure 1). Study population (PSD, pilonidal sinus disease). Surgical treatment I&D was the most frequently performed procedure, conducted in 205/208 patients (99%). Other techniques employed included pit picking with phenol treatment (n = 1), excision with midline closure (n = 1) and excision with off‐midline closure (n = 1). These three additional techniques were excluded from further analysis due to the limited number of cases. Patient characteristics and symptoms The mean age (SD) of the patients was 28 (11.4) years, and 129 of included patients (62.9%) were male. A total of 49 patients (23.9%) had previously undergone one or more surgeries for PSD (Table 1). Apart from the notable symptom of pain in the case of an abscess, the predominant complaint reported by patients was embarrassment, experienced by 109/190 patients (57.3%). Additionally, 76/202 patients (37.6%) reported wound fluid/pus discharge. Other reported symptoms included itching, noted by 53/197 patients (26.9%), and blood loss, reported by 44/200 patients (22%). TABLE 1Patient characteristics (N = 205).CharacteristicMean age (years) (SD)28 (11.4)Missing, n 1Male, n (%)129 (62.9)Mean BMI (SD)27 (5.4)Missing, n 17Prior surgical treatment of PSD (including abscess), n (%)49 (23.9)History of PSD abscess, n (%)37 (18)Diabetes mellitus, n (%)9 (4.4)Immunosuppressant use, n (%)1 (0.5)Smoking, n (%)88 (46.3)Missing, n 15 Patient characteristics (N = 205). Perioperative data I&D was performed under general anaesthesia in 101/205 patients (49.3%). Local infiltration anaesthesia was utilized in 49 out of 205 patients (23.9%) while locoregional anaesthesia was employed in 54 out of 205 patients (26.3%). One patient (0.5%) received procedural sedation and analgesia. Complications Nine out of 205 patients (4.4%) experienced complications (Table 2). After 1 week, 70.4% of the patients still experienced symptoms. After 6 weeks, the proportion of patients experiencing symptoms decreased to 46.8%. TABLE 2Postoperative complications.ComplicationTreated byAny complication9/205 (4.4%)Type of complication Seroma, n (%) Bleeding, n (%) Infection, n (%) Hypergranulation, n (%) Residual disease, n (%) 1 (0.49) 1 (0.49) 2 (0.99) 2 (0.99) 3 (1.48) Conservative (1) Conservative (1) Antibiotics (2) Silver nitrate (2) Excision with secondary wound healing (1), pit picking with phenol (1), debridement (1) Note: Data are frequencies and percentages. Postoperative complications. Seroma, n (%) Bleeding, n (%) Infection, n (%) Hypergranulation, n (%) Residual disease, n (%) 1 (0.49) 1 (0.49) 2 (0.99) 2 (0.99) 3 (1.48) Conservative (1) Conservative (1) Antibiotics (2) Silver nitrate (2) Excision with secondary wound healing (1), pit picking with phenol (1), debridement (1) Note: Data are frequencies and percentages. Secondary wound healing Of the 205 I&D operations performed, 87 (42.2%) resulted in successful healing after a median clinical follow‐up of 38 days (IQR 15–48 days). The median time to closure was 43 days (95% CI 39–47 days) for I&D (Figure 2). Kaplan–Meier curve demonstrating the length of time to heal. Multivariable regression analysis was conducted on successful wound healing. Neither history of PSD abscess (OR 1.091, 95% CI 0.496–2.400; p = 0.829) nor smoking (OR 1.264, 95% CI 0.682–2.344; p = 0.456) showed a significant association with the outcome (Data S2). Resumption of daily activities Of the 205 patients, 123 (60%) resumed their daily activities after a median clinical follow‐up of 38 days. The median time to resume daily activities was 14 days (95% CI 12–16 days) for I&D (Figure 3). Kaplan–Meier curve demonstrating the length of time to resume daily activities. Outcomes 1 year after surgery One year after surgery, questionnaires from 158 of 205 patients (77.1%) were available for analysis. A total of 47 patients did not complete the questionnaire after a single reminder, resulting in loss to follow‐up. Fifteen of the 205 patients (7.3%) developed a recurrent abscess within 1 year, with 12 cases (5.9%) during follow‐up at the outpatient visit. Among these 15 patients, 10 underwent additional I&D while the remaining five were managed conservatively. A univariable regression analysis found that smoking was not significantly associated with recurrent abscesses (OR 1.296, 95% CI 0.450–3.730; p = 0.630; Data S2). Eighteen of the 205 patients (8.8%) underwent additional surgical treatment for symptomatic chronic PSD within 1 year of follow‐up, with three cases occurring during follow‐up at the outpatient visit. The types of surgery these patients underwent varied (see Table 3). TABLE 3Types of additional surgery for symptomatic chronic pilonidal sinus disease (N = 18).Type of re‐operationExcision with secondary wound healing, n (%)5 (27.7)Excision with midline closure, n (%)1 (5.6)Bascom cleft lift, n (%)1 (5.6)Pit picking with hydrogen peroxide, n (%)3 (16.6)Pit picking with laser, n (%)3 (16.6)Pit picking with silver nitrate, n (%)1 (5.6)Pit picking with phenol, n (%)1 (5.6)Debridement, n (%)2 (11.1)Type unknown, n (%)1 (5.6)Abbreviation: PSD, pilonidal sinus disease. Types of additional surgery for symptomatic chronic pilonidal sinus disease (N = 18). Abbreviation: PSD, pilonidal sinus disease. Of the five domains regarding QoL, pain/discomfort (27.1%) and anxiety/depression (10.2%) regarding recurrence were the most frequently reported problems in patients with acute PSD at 1‐year post‐surgery (Figure 4). Half of the patients experienced postsurgical wound healing as problematic (Figure 5). Quality of life 1 year after surgery for acute pilonidal sinus disease. Patient‐reported experience measures 1 year after surgery for acute pilonidal sinus disease. DISCUSSION This prospective observational study showed that 30% of patients seeking surgical treatment for symptomatic PSD have acute PSD. Only one study in the literature describes that roughly half of all cases of PSD first present with an abscess [21]. I&D was the most frequently performed procedure for acute PSD, while in three patients other treatments were performed, possibly due to a limited abscess and the surgeon opting for a single‐stage definitive treatment. Three international guidelines recommend paramedian incision in the presence of an acute abscess [15, 16, 22]. Lateral incision, which can shorten healing time [23], is recommended along with proper curettage of the abscess cavity to remove all inflammatory debris and hairs, to achieve higher rates of complete healing and lower recurrence rates [24]. However, the exact surgical technique used was not assessed in the current study. The recurrent abscess rate within 1 year was 7.3%. Twelve recurrent abscesses were already observed during the short follow‐up period, seven of which underwent a reoperation. Inadequate drainage following the initial operation could be a reason, and smoking was not associated with an increased risk of recurrent abscesses. An interesting, and previously unreported, finding from this prospective study is that 91.2% of the patients did not undergo additional surgical treatment for symptomatic chronic PSD within 1 year of follow‐up. This finding challenges the common idea and practice of definitive surgical treatment following I&D for a pilonidal abscess after resolution of the inflammation. This is recommended in some national guidelines [15, 16], but should be reconsidered to prevent unnecessary surgery. Reducing unnecessary surgeries fits into current sustainability initiatives. Additionally, a single‐step procedure for acute PSD by combining I&D with pilonidal excision has not been shown to alter recurrence rates, length of hospital stay or overall time of healing [25]. There is limited evidence to suggest that patients treated with local excision of diseased tissue had a trend toward increased days off work (14 vs. 7 days; p = 0.06) [25]. Therefore, de‐implementation of (additional) definitive surgical treatment should probably be considered. At the last outpatient visit, successful wound healing was observed in less than half (42.2%) of the patients. This is lower than reported by others [21, 22]. A publication by Allen‐Mersh showed that simple I&D healed 58% of patients within 10 weeks [21]. This author and another have stated that for those healing initially, surgical treatment eventually becomes necessary in 15%–40% at an average of 6 months from surgery [21, 26]. Some researchers have stated that proper curettage improves the rate of wound healing and potentially avoids the need for a second procedure [22]. In a study by Mahmood et al., 90% of patients healed completely at 1 month with curettage, compared with only 58% healed at 10 weeks without curettage [27]. In a randomized clinical trial of acute abscesses undergoing I&D with or without curettage of the abscess cavity, curettage was associated with significantly greater complete healing at 10 weeks (96% vs. 79%; p = 0.001) and lower incidence of recurrence <65 months postsurgery (10% vs. 54%; p < 0.001) [24]. This was reinforced in a meta‐analysis of the laying open and curettage technique, which demonstrated a low recurrence rate of 4.5% with a low complication rate of 1.4% [28]. We also consider proper curettage to be a critical component of an effective I&D procedure. Unfortunately, data on whether this was part of the surgical treatment were not available. Another explanation for the need for additional surgery could be the failure of I&D alone to address the underlying risk factors for recurrent PSD, such as a deep intergluteal cleft and recurring loose hair and debris in the intergluteal cleft [21, 29, 30, 31]. The disappointing healing rates in this study may be attributed to impaired wound healing associated with midline wounds in the intergluteal cleft, as known from excision and secondary wound healing. It seems that even though wounds after I&D are generally smaller than after excision with secondary wound healing, they still need considerable time to heal. Additionally, the high percentage of smokers (47.4%) in the present cohort may have contributed to the observed impaired healing outcomes despite our finding that smoking was not statistically significantly associated with impaired healing. The literature describes studies with conflicting results regarding smoking as a risk factor for impaired wound healing [32, 33, 34, 35]. Perhaps we should define unhealed wounds as treatment failure in order to distinguish these patients from recurrent PSD. In recurrent PSD, the skin had closed after I&D and patients were without symptoms. Sometime later, new pits or sinus develop, resulting in recurrent symptoms. The median time to wound closure and resumption of daily activities after I&D were 43 and 14 days, respectively. These durations are higher than reported in the literature [25], possibly due to using the outpatient visit date as a reference instead of the actual date. When comparing patient characteristics with those with chronic PSD [36], the acute PSD group showed higher proportions of female patients (37.1% vs. 17.3%) and smokers (46.3% vs. 32.3%). Others reported that smokers develop abscesses significantly more frequently than nonsmokers, mainly when the patient is overweight and/or female [20]. Therefore, smoking cessation should be considered as a standard recommendation. To our knowledge, data on QoL and patient satisfaction after I&D in acute PSD have not been previously reported. This highlights a gap in the existing literature and underscores the need for further investigation. QoL 1‐year postsurgery shows that almost 30% of patients experience pain or discomfort. This suggests that there may still be ongoing disease activity after I&D and these patients may need further evaluation at the outpatient clinic. Pain could also be due to fibrosis or scarring. Additionally, 10% of patients reported feelings of anxiety or depression regarding recurrence. This corresponds with the outcomes observed 1 year after surgery for chronic PSD [37]. The overall satisfaction with the care provided was high 1 year after surgery. However, half of the patients reported wound problems postsurgery, which is a common issue in PSD surgery. This high percentage suggests that enhanced wound care or hygiene protocols are needed. The strength of this study lies in its prospective nature and the large number of included patients, without any selection bias based on age or comorbidity. This enabled an assessment of standard Dutch practice and the clinical outcomes of I&D for pilonidal abscesses. There are also several limitations. The study's relatively short follow‐up period may not accurately represent recurrent abscess (or treatment failure) rates. Moreover, relying on patient‐reported outcomes at 1 year of follow‐up exacerbates these limitations. Extending the duration of follow‐up could offer greater insight into true rates of abscess recurrence that might occur up to 5 years postoperatively. Finally, it is important to note that 22.9% of participants did not complete the questionnaires, potentially introducing nonresponse bias. In conclusion, of all the patients presenting with PSD in this prospective national study cohort, 30% had a pilonidal abscess. Incision and drainage is the logical surgical procedure and shows a low complication rate but a disappointing rate of successful wound healing (in less than half of the patients). In this study 91.2% of patients did not undergo additional surgical treatment for symptomatic chronic PSD within 1 year of follow‐up. Based on these results, additional surgical treatment after I&D may not be necessary in many cases. Continuation of our data in the long term is necessary to explore the long‐term recurrence rate of this cohort. AUTHOR CONTRIBUTIONS Eleonora A. Huurman Conceptualization; investigation; writing – original draft; methodology; validation; writing – review and editing; formal analysis; supervision. A. A. Sophie den Otter Writing – original draft; methodology; validation; formal analysis. Christel A. L. de Raaff Conceptualization; investigation; methodology; supervision; writing – review and editing. Rosaline van den Berg Conceptualization; investigation; methodology; writing – review and editing; supervision. Sara J. Baart Conceptualization; investigation; methodology; writing – review and editing; supervision. Bas P. L. Wijnhoven Supervision; writing – review and editing; methodology; conceptualization; investigation. Ruben Schouten Conceptualization; investigation; methodology; writing – review and editing; supervision. Edgar J. B. Furnée Supervision; writing – review and editing; methodology; investigation; conceptualization. Robert M. Smeenk Conceptualization; investigation; methodology; writing – review and editing; supervision. Boudewijn R. Toorenvliet Conceptualization; investigation; writing – review and editing; methodology; supervision. FUNDING INFORMATION There is no funding. CONFLICT OF INTEREST STATEMENT None declared. ETHICS STATEMENT The medical ethics committee of the University Medical Center Utrecht approved the study design (protocol number 20‐671/C). INFORMED CONSENT Patients signed informed consent. Supporting information Data S1‐S2.